Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Highly Active Antiretroviral Therapy Using Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Antiretroviral Naive HIV-Infected Subjects

NCT00740064 is registered in ClinicalTrials.gov with Denver Infectious Disease Consultants, PLLC as lead sponsor.

NCT NCT00740064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00740064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Highly Active Antiretroviral Therapy Using Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Antiretroviral Naive HIV-Infected Subjects
Lead sponsor
Denver Infectious Disease Consultants, PLLC
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2008
Completion date
November 30, 2009
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections